Fair Richard A. Insider Trades

Insider Trading History

Track insider trading activity for Fair Richard A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Enliven Therapeutics
Enliven Therapeutics ELVN
PRESIDENT AND CEO
Holding Value $42.5M 875,000 shares
Last Trade
Dec 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.4M 875,000 shares
$18.77
$48.60
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $29.9k 400,000 shares
Last Trade
Aug 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$576k 400,000 shares
$1.44
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $19.8k 265,000 shares
Last Trade
Aug 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$771k 265,000 shares
$2.91
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $19.8k 265,000 shares
Last Trade
Aug 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$763k 265,000 shares
$2.88
$0.07
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $3.43k 42,223 shares
Last Trade
Jun 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 42,223 shares
$5.97
$0.08
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $21.4k 286,000 shares
Last Trade
Dec 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$849k 286,000 shares
$2.97
$0.07
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $3.26k 40,138 shares
Last Trade
Jun 04, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$260k 40,138 shares
$6.48
$0.08
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $374 5,000 shares
Last Trade
Mar 17, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20k 5,000 shares
$4.00
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $94k 1,257,000 shares
Last Trade
Feb 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 1,257,000 shares
$13.60
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $4.98k 66,561 shares
Last Trade
Sep 10, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$508k 40,000 shares
$12.70
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $1.99k 26,561 shares
Last Trade
Aug 21, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$190k 20,000 shares
$9.48
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $22.4k 300,000 shares
Last Trade
Jun 11, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.61M 300,000 shares
$18.70
$0.07
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $2.35k 28,882 shares
Last Trade
Jun 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$423k 28,882 shares
$14.66
$0.08
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $22.4k 300,000 shares
Last Trade
Feb 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1M 300,000 shares
$33.50
$0.07
Clovis Oncology
Clovis Oncology CLVS
Director
Holding Value $2.1k 25,848 shares
Last Trade
Oct 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$722k 25,848 shares
$27.92
$0.08
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $16.8k 225,000 shares
Last Trade
Jul 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.4M 225,000 shares
$77.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $16.8k 225,000 shares
Last Trade
Jan 02, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.8M 225,000 shares
$92.30
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
President And CEO
Holding Value $37.4k 500,000 shares
Last Trade
Jan 30, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.4M 500,000 shares
$118.70
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up